Thousand Oaks Biopharmaceuticals has raised $109M in total funding. Latest round: Series B. Backed by CICC Jiatai, Goldstone Investment, CCB International.
Thousand Oaks Biopharmaceuticals has raised $109M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B announced in July 2026. The round record for Thousand Oaks Biopharmaceuticals runs through 2026; nothing later has been disclosed. Investors on record include CICC Jiatai, Goldstone Investment, CCB International, Wens Investment, Shanghai Huaxu Investment. 5 distinct backers are named across the disclosed rounds.
Round data for Thousand Oaks Biopharmaceuticals is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies and backer lists below.
Company funding database · Investor directory · Founder database · Mega-rounds 2026